GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Healthsouth Corporation (HLS) [hlAlert]

Rating:
Buy HLS
up 71.14 %

Healthsouth Corporation (HLS) rated Buy with price target $24 by Mizuho

Posted on: Thursday,  Feb 16, 2012  8:25 AM ET by Mizuho

Mizuho rated Buy Healthsouth Corporation (NYSE: HLS) on 02/16/2012, when the stock price was $20.17. Since
then, Healthsouth Corporation has gained 71.15% as of 04/15/2014's recent price of $34.52.
If you would have followed this Mizuho's recommendation on HLS, you would have gained 71.14% of your investment in 789 days.

HealthSouth Corporation (HealthSouth) is a provider of inpatient rehabilitative healthcare services. The Company operates 93 inpatient rehabilitation hospitals, six freestanding long-term acute care hospitals (LTCHs), 49 outpatient rehabilitation satellites (operated by its hospitals), and 25 licensed, hospital-based home health agencies. Its outpatient rehabilitation facilities offer a range of rehabilitative healthcare services, including physical, occupational and speech therapies treating a range of neurological and orthopedic conditions. LTCHs provide medical treatment to patients with chronic diseases and/or complex medical conditions. In August 2008, the Company acquired an inpatient rehabilitation unit at the Medical Center of Arlington in Texas. In August 2008, it acquired an inpatient rehabilitation hospital in Midland, Texas from Rehabcare Corporation. On July 31, 2008, it acquired The Rehabilitation Hospital of South Jersey.

Mizuho
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/16/2013 8:25 AM Buy
None
31.91 39.00
as of 12/31/2012
1 Week up  0.33 %
1 Month down  -4.00 %
3 Months down  -12.26 %
1 YTD down  -12.98 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/26/2013 8:25 AM Buy
None
33.05 36.00
7/20/2012 8:26 AM Buy
None
24.26 28.00
2/16/2012 8:25 AM Buy
None
20.17 24.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy